Michael Plank, University of Canterbury; Shaun Hendy, University of Auckland, and Siouxsie Wiles, University of …
Read More »AFT Pharmaceuticals mulls NZX listing as Milford, US investor take 10 percent stake
Privately held drugs developer and reseller AFT Pharmaceuticals is contemplating a listing on the NZX, having attracted a 10.6 percent equity investment from a US specialist healthcare investment fund and Auckland-based Milford Asset Management. Companies Office records show Capital Royalty, with headquarters in Houston, Texas, has taken a 7.58 percent stake in Auckland-based AFT, leaving a 3.03 percent stake taken …
Read More »
newzealandinc.com Informed. Influential. Indispensable.






